Sangamo Therapeutics Inc. (NASDAQ: SGMO)
$0.46
+0.0321 ( +7.46% ) 2.0M
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
Market Data
Open
$0.46
Previous close
$0.43
Volume
2.0M
Market cap
$95.37M
Day range
$0.42 - $0.48
52 week range
$0.29 - $1.67
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | May 29, 2024 |
4 | Insider transactions | 1 | May 29, 2024 |
4 | Insider transactions | 1 | May 29, 2024 |
4 | Insider transactions | 1 | May 29, 2024 |
4 | Insider transactions | 1 | May 29, 2024 |
8-k | 8K-related | 15 | May 09, 2024 |
10-q | Quarterly Reports | 67 | May 09, 2024 |
8-k | 8K-related | 14 | Apr 30, 2024 |
def | Proxies and info statements | 39 | Apr 19, 2024 |
ars | Annual reports | 1 | Apr 19, 2024 |